Encouraging results from Perth

Promising results from Perth were recently described in The R&D Review (http://www.australianrdreview.com/).

The Ray & Bill Dobney Cell and Tissue Therapies (CTTWA) facility housed at The Royal Perth Hospital received a subsidy from RISS to reduce the manufacturing costs of mesenchymal stromal cells for treatment of Graft-Versus-Host-Disease. Whilst several patients have been treated with encouraging results the outcome for Lane Martino in particular has been very positive.
 
Click here to view the publication.